Факторы риска неблагоприятного прогноза и послеоперационных осложнений у больных сахарным диабетом 2 типа с ишемической болезнью сердца, перенесших коронарное шунтирование
Диссертация
В настоящее время для восстановления коронарного кровотока наиболее часто проводятся операции аортокоронарного шунтирования (АКШ) и чрез-кожной транслюминальной коронарной ангиопластики (ЧТКА). В нескольких рандомизированных исследованиях (Toulouse, Goy, ERASI, GABI, С ABM, EAST) проводилось сравнение двух интервенционных методов лечения в популяции больных СД — ЧТКА и АКШ, однако, при этом… Читать ещё >
Содержание
- Обозначения и сокращения
- ГЛАВА 1. ОБЗОР ЛИТЕРАТУРЫ
- 1. 1. Взаимосвязь сахарного диабета и атеросклероза
- 1. 2. Современные подходы к консервативному лечению атеросклероза у больных сахарным диабетом
- 1. 3. Реваскуляризация миокарда у больных сахарным диабетом
- ГЛАВА 2. МАТЕРИАЛЫ И МЕТОДЫ
- 2. 1. Группы обследованных больных
- 2. 2. Методы обследования больных ишемической болезнью сердца
- 2. 3. Статистическая обработка полученных результатов.39*
- ГЛАВА 3. КЛИНИКО-ЛАБОРАТОРНЫЕ СОПОСТАВЛЕНИЯ У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА.41*
- 3. 1. Клиническая характеристика обследованных больных
- 3. 2. Характер проводимой терапии у больных ишемической болезнью сердца
- 3. 3. Показатели углеводного и липидного метаболизма у больных ишемической болезнью сердца
- ГЛАВА 4. РЕЗУЛЬТАТЫ ИНСТРУМЕНТАЛЬНЫХ МЕТОДОВ ИССЛЕДОВАНИЯ БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА
- 4. 1. Результаты суточного мониторирования электрокардиограммы у больных ишемической болезнью сердца
- 4. 2. Результаты эхокардиографического исследования у больных ишемической болезнью сердца
- 4. 3. Результаты коронарографического исследования больных ишемической болезнью сердца
- ГЛАВА 5. ОСОБЕННОСТИ ИНТРАОПЕРАНИОННОГО ПЕРИОДА У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА ПРИ ПРОВЕДЕНИИ АОРТО-КОРОНАРНОГО ШУНТИРОВАНИЯ
- 5. 1. Основные показатели интраоперационного периода
- 5. 2. Осложнения интраоперационного периода у больных ишемической болезнью сердца
- 5. 3. Характер инотропной поддержки во время проведения аорто-коронарного шунтирования у больных ишемической болезнью сердца
- ГЛАВА 6. ОСОБЕННОСТИ ПОСЛЕОПЕРАЦИОННОГО ПЕРИОДА У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА
- 6. 1. Длительность пребывания больных в отделении реанимации
- 6. 2. Послеоперационные осложнения у больных ИБС, подвергшихся операции аортокоронарного шунтирования
Список литературы
- Александров А.А. Недостаточность кровообращения, сахарный диабет и p-блокаторы/ А. А. Александров // Русский мед. журн.- 2007.- № 9.- С.727−730.
- Алмазов В.А. Метаболический сердечно-сосудистый синдром/ В. А. Алмазов, Я. В. Благосклонная, Е. В. Шляхто, Е. И. Красильникова.- СПб.: Изд-во СПбГМУ, 1999.-208 с.
- Благосклонная Я.В. Метаболический сердечно-сосудистый синдром/ Я. В. Благосклонная, Е. В. Шляхто, Е.И. Красильникова// Ученые записки.-2002.- Т. IX, № 3.- С. 111−115.
- Васюк Ю.А. Метаболический синдром: новые аспекты старой проблемы/ Ю. А. Васюк и др. // Артериальная гипертензия.- 2007.- Т.13, № 2.- С. 113 118.
- Дедов И.И. Сахарный диабет: реперфузионные осложнения и проблемы кардиопротекции/ И. И. Дедов, А.А. Александров// Consilium Medicum.-2006.- Т.8, № 9.- C. l-27.
- Дедов И.И. Сахарный диабет и артериальная гипертензия/ И. И. Дедов, М. В. Шестакова.- М.: Изд-во МИА, 2006.- 320−329.
- Затейщиков Д.А. Сахарный диабет — новое показание для применения статинов. Кто на очереди?/ Д.А.Затейщиков// Фарматека.- 2004.- № 2, — С. 1−4.
- Кобалава Ж.Д. Субклиническое воспаление и окислительный статус у больных с нелеченным сахарным диабетом 2 типа/ Ж. Д. Кобалава, С. В. Виллевальде, Х. В. Исакова, Н.И. Гудгалис// Артериальная гипертензия.- 2008- Т.14, № 1.- С.151−161.
- Крылов A.JI. Ангиопластика коронарных артерий у больных/ A.JI. Крылова// Кардиология.- 2008.- Т.48, № 12.-55−58.
- Мазуров В.И. Изменение эндотелиальной функции у больных с коронарным атеросклерозом и возможности ее коррекции/ В. И. Мазуров, С. В. Столов, И.А. Иванова// Эффектная терапия.- 2007.- Т. 13, № 1.- С.32−36.
- Мычка В.Б., Чазова И. Е. Сердечно-сосудистые осложнения сахарного диабета тип 2/ В. Б. Мычка, И.Е. Чазова// Consilium medicum.- 2003.- Т.5, № 9.-С.504−509.
- Оганов Р.Г., Масленникова Г. Я. Смертность от сердечно-сосудистых и других неинфекционных заболеваний среди трудоспособного населения России/ Р. Г. Оганов, Г. Я. Масленникова// Кардиоваскулярная терапия и профилактика.- 2002.-№ 3.- С.4−8.
- Оганов Р.Г., Масленникова Г. Я. Проблемы сердечно-сосудистых заболеваний в Российской Федерации и возможности их решения// Российский кардиологический журнал.- 2000.- № 4.- С.7−11.
- Салтыков Б.Б. Патогенез диабетической микроангиопатии/ Б.Б. Салтыков// Сов. мед. 1987.- № 1.- С. 39−45.
- Салтыков Б.Б. Мозфогенез диабетической микроангиопатии/ Б. Б. Салтыков, О. Я. Кауфман, В. К. Беликов, О.И. Шубина// Арх. патол. — 1994.- 1991.-№ 7.- С.60−65.
- Соколов Е.И. Сахарный диабет и атеросклероз/ Е. И. Солоков.- М.: Медицина, 1996.
- Хадилаш JI.A. Кластеры компонентов метаболического синдрома у больных сахарным диабетом II типа/ JI.A. Хадилаш и др.// Пробл. эндокри-нол.- 2001.- Т. 47, № 4.- с. 30−34.
- Чазова И.Е., Мычка В. Б. Метаболический синдром/ И. Е. Чазова, В. Б. Мычка.-М.: Медиа Медика, 2004, — 168 с.
- Шестакова М.В. Сахарный диабет и ишемическая болезнь сердца: влияние инсулинорезистентности и ее коррекции на сердечнососудистый прогноз/ М.В. Шестакова// Болезни сердца и сосудов, — 2006.- № 2.- С.4−7.
- Шляхто Е.В. Метаболический синдром: прошлое, настоящее, будущее/ Е. В. Шляхто, Е. И. Баранова, О. Д. Беляева, О.О. Большакова// Эфферентная терапия.- 2007.- Т. 13, № 1.- С.74−78.
- Шляхто Е. В, Инсулинорезистентность и артериальная гипертензия. Современные подходы к лечению/ Е. В. Шляхто и др.// Клиническая и экспериментальная кардиология.- СПб.: Изд-во ООО «Академический медицинский центр», 2005.- С. 188−198.
- Шнейдер Ю.А. Коронарное шунтирование у женщин с клиническими проявлениями метаболического синдрома/ Ю. А. Шнейдер, А. В. Красиков, К.В. Кузнецов// Эфферентная терапия.- 2007.- Т.13, № 1.- С. 78−82.
- Abizaid A. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation/ A. Abizaid et al.// J. Am. Coll. Cardiol.- 1998.- Vol. 32.- P. 584−589.
- American Diabetes Association- Standards of medical care in diabetes// Diabetes Care.- 2004.- Voll27.- P. S15-S35.
- American Diabetes Association. Dyslipidemia Management in adults with Diabetes// Diabetes Care.- 2004.- Vol.27, Suppl. 1.- P. S68-S71.
- American Diabetes Association, National Heat Lang and Blood Institute, American Heat Association// Circulation.- 1999.- Vol. 100.- p. 1132−1133.
- American association of clinical endocrinologists medical guidekines for clinical practice for the management of diabetes mellitus// Endocrine practice.-2007.- Vol.13, № 3, suppl. 1.- P.3−68.
- Barsness G. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty/ G. Barsness et al.// Circulation.- 1997.-Vol.96.- P.2551−2556.r
- Bartnik M. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro heart Survey on diabetes and the heart/ M. Bartnik// Eur. Heart J.- 2004.- Vol. 25, N21.- P. 1880−1890.
- Bartnik M. Abnormal glucose tolerance a common risk factor in patients with acute myocardial infarction in comparison with population-based controls/ M. Bartnik et al.// J. Intern. Med.- 2004.- Vol. 256.- P. 288−297.
- Barwell N. Exercise training has greater effects on insulin sensitivity in daughters of patients with type 2 diabetes than in women with no family history of diabetes/N. Barwell et al.// Diabetologia.- 2008.- Vol.52, № 10.- P. 1912−1919.
- Bilheimer D. The lipoprotein receptor concept/ D. Bilheimer// Drugs.-1988.- Vol. 36, Suppl. 3.- P. 55−62.
- Calafiore A. Effect of diabetes on early and late survival after isolated first coronary bypass surgeiy in multivessel disease/ A. Calafiore et al.// J. Thorac. Cardiovasc. Surg.- 2003.- Vol. 125, № 1.-P.144−154.
- Canibus P. Metabolic syndrome dose not increase angiographic restenosis rates after drug-eluting stent implantation/ P. Canibus et al.// Metabolism.- 2008.-Vol. 57, № 5.- P.593−597.
- Carrozza J. Diabetes mellitus is assiciated with adverse 6-month angiographic and clinical outcome following coronary stenting/ J. Carrozza et al.// Circulation.- 1998.- Vol. 98.- P. l-79.
- Carrozza J. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus/ J. Carrozza et al.// Ann. Intern. Med.- 1993.-Vol.118.- P.344−349.
- Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States. Atlanta,
- Georgia: US Departament of Health and Human Services, Centers for Disease Control and Prevention- 2004. Accessed August 30, 2005.
- Chapman J. Fibrates: Therapeutic review/ J. Chapman// Diabetes and Vascular Disease.- 2006.- Vol. 6.- P. 11−18.
- Charlton-Manys V. Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative atorvastatin Diabetes Study (CARDS)/ V. Charlton-Manys et al.// Diabetologia.- 2009.- Vol.52, № 2.- P. 218−225.
- Chen H.F., Li C.Y. Effect-modifications by age and sex on the risks of coronary artery disease and revascularization procedures in relation to diabetes/ H.F. Chen, C.Y. Li// Diabetes Res. Clin. Pract.- 2007.- Vol. 75, № 1.- P. 88−95.
- Chikwe J. Safety and efficacy concerns regarding elective coronary artery surgery in patients with prior coronary stents/ J. Chikwe J. et al.// Eur. Heart J.-2007.- Vol. 28, № 10.- P. 1265.
- Cullen K. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton. Western Australia-13 year study/ K. Cullen, N. Stenhouse, K. Wearne, T. Welborn// J. Chronic Dis.- 1983.- Vol. 36.- P. 371 377.
- Dandona P. Effect of hyperglycemia and insulin in acute coronary syndrome/ P. Dandona et al.// Am. J. Cardiol.- 2007.- Vol. 99.- P.12H-19H.
- Davi G. Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and independent diabetics/ G. Davi et al.// Tromb. Res.- 1982.-Vol. 26.- P. 359−370.
- Detre K. et al. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (ВАШ)/ K. Detre et al.// Circulation.- 1999.- Vol.99.-P.633−640.
- Dhindsa S. Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factors kB in mononuclear cells/ S. Dhindsa et al.// Metabolism.- 2004.- Vol. 53.- P. 330−334.
- Douglas J. Intercellular adhesion molecule-1 (ICAM-1): a pedictor if vascular complications in diabetes mellitus/ J. Douglas et al.// In: 4th Int. Symp. On Multiple Risk Factors in Cardiovascular. Dis.- Washington, 1997.- P.33 (Abstr.).
- Dunning J. Stentless vs. stented aortic valve bioprostheses: a prospective randomized controlled trial/ J. Dunning et al.// Eur. Heart J.- 2007.- Vol. 28, № 19.-P. 2369−2374.
- Eeg-Olafsson K. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients/ K. Eeg-Olafsson et al.// Diabetologia.- 2009.- Vol. 52, № 1.- P. 65−74.
- Elezi S. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement/ S. Elezi et al.// J. Am. Coll. Cardiol.- 1998.- Vol. 32.-P. 1866−1873.
- Elezi S. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement/ S. Elezi et al.// J. Am. Coll. Cardiol.- 1993.- Vol. 32.- P. 1866−1873.
- Engelgau M., Narayan K., Herman W. Screening for type 2 diabetes/ M. Engelgau, K. Narayan, W. Herman// Diabetes Care.- 2000.- Vol. 23.- P.1563−1580.
- Ernst S. Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting. Long-terrm results/ S. Ernst et al.// J. Thoracic Cardiovasc. Surg.- 1987.- Vol.93.- P.268−275.
- Espelt A. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century/ A. Espelt et al.// Diabetologia.- 2008.- Vol. 51, № 11.- P. 1971−1980.
- Evolving treatment paradigms for vascular risk reduction in type 2 diabetes. Report of an international symposium held in Barselona // The British journal of Diabetes and Vascular Disease.- 2006.- Vol.6, N1.- P. S1-S12.
- Feit F. Long-Term Clinical OutCome in the Bypass Angioplasty Revascularization Investigation Registry/ F. Feit et al.// Circulation.- 2000.- Vol.101.-P.2795−2802.
- Fish L. Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting/ L. Fish et al.// Am. J. Cardiol.- 2003.- Vol.92., №l.-P.74−76.
- Fontbonne A. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up/ A. Fontbonne et al.//Diabetologia- 1991.- Vol. 34.- P. 356−361.
- Fruchart J., Staels В., Duriez P. PPARS, metabolic disease and atherosclerosis/ J. Fruchart, B. Staels, P. Duriez// Pharmacol. Res.- 2001.- Vol. 44.- P. 345−352.
- Furnary A., Braithwaite S. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy/ A. Furnary, S. Braithwaite// Am. J. Cardiol.- 2006.- Vol. 98.- P.557−564.
- Gerich J. Type 2 diabetes mellitus is associated with multiple cardiome-tabolic risk factors/ J. Gerich et al.// Clin. Cornerstone.- 2007.- Vol. 8, № 3.- P. 5368.
- Ghanim H. Circulating mononuclear cells in the obese are in a proinflammatory state/ H. Ghanim, A. Aljada, D. Hofmeyer// Circulation.- 2004.-Vol. 110.-P.1564−1571.
- Grip O. Atorvastatin activates PPARg and attenuates the inflammatory response in human monocytes/ O. Grip, S. Jancianskiene, S. Lindgren// Inflamm. Res.-2002.- Vol. 51.-P. 58−62.
- Grundy S. Effectiveness and Tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)/ S. Grundy// Am. J. Cardiol.- 2005.-Vol.95, № 4.- P. 462−468.
- Guidlines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary// Eur. Heart J.- 2007.-Vol. 28,-№ 1.- P.88−13.
- Gum P. Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients/ P. Gum et al.// Circulation.- 1997.- Vol.96.- P. II7-II10.
- Gustafsson I. Unrecognized glycometabolic disturbance as measured by hemoglobin Ale is associated with a poor outcome after acute myocardial infarction/ I. Gustafsson, C. Kistorp, M. James// Am. Heart J.- 2007.- Vol. 154.- P. 470−476.
- Jensen T. Features of endothelial dysfunction in early diabetic nephropathy/ T. Jensen, J. Bjerre-Knudsen, B. Feldt-Rasmussen// Lancet.- 1989.- Vol.1.- P. 461 463.
- Johansen K. Hyperlipidaemi ved diabetes mellitus. Pathogenese, diagnose og medikamentel behanding/ K. Johansen// Ugeskr. Laeger.- 1990, — Vol.152.- P.584−588.
- Johnston M., Nesto R. Diabetes mellitus and Heart Disease/ M. Johnston, R. Nesto// Diabetes Mellitus.- 2005.- Vol. 14, — P. 305−328.
- Johnson S. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45−74 years of age/ S. Johnson et al.// Diabetes Care.- 2005.- Vol. 28.- P.307−311.
- Juhanvague I. Involvement of the hemostatic system in the insulin resistance syndrome A study of 1500 patient with angina pectoris/ I. Juhanvague, S. Thompson, J. Jesoersen// Artheroscler. Tromb.- 1993.- Vol. 12.- P. 1865−1873.
- Haffner S. Mortality from coronary heart disease in subject with type 2 diabetes and nondiabetic subjects with and without prior myocardial infarction/ S. Haffner et.al.// N. Engl. J. Med.-1998.-Vol.339.- P.229−234.
- Halkos M. Elevated preoperative hemoglobin Ale level is associated with reduced long-term survival after coronary artery bypass surgery/ M. Halkos et al.// Ann. Thorac. Surg.- 2008.- Vol. 86, № 5.- P. 1431−1437.
- Haller H. Mechanisms of early atherogenesis: cellular effects of calcium — channel blockers/ H. Haller// J. Cardiovascular Pharmacol.- 1997.- Vol.30 (Suppl.3).-P. S1-S8.
- Harris R. Screening adults for type 2 diabetes: review of the evidence for the U.S. Preventive Services Task Force/ R. Harris et al.// Ann. Intern. Med.- 2003.-Vol. 138.- P.215−229.
- Hannan E. Adult open-heart surgery in New York state. An analysis of risk factors and hospital mortality rate/ E. Hannan et al.// JAMA.- 1990.- Vol.264.-P.2768−2774.
- Hasdai D. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy/ D. Hasdai et al.// J. Am. Coll. Cardiol.- 2000.- Vol. 35.- P. 1502−1512.
- Heart Protection Study Collaborative Group. MRC/BHF heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals (HPS): a randomized placebo-controlled trial// Lancet.- 2002.- Vol. 361.- P. 2005−2016.
- Herlitz J. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting/ J. Herlitz et al.// Diabet. Care.- 1996.-Vol. 19.-P. 698−703.
- Karam C. Nine-year follow-up of balloon-expandable Palmaz-Schatz stent in patients with single-vessel disease/ C. Karam et al.// Cathet Cardiovasc. Inter-vent.- 2000.- Vol.50.- P. 170−174.
- Keech А. Влияние фенобарбитала на необходимость лазерного лечения диабетической ретинопатии (исследование FIELD): рандомизиро-ванное контролируемое исследование/ A. Keech et al.// Артериальная гипер-тензия.-2008.- Т. 14, № 3.- С. 245−256.
- Kip К. Coronary angioplasty in diabetic patients: the National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry/ K. Kip et al.//Circulation.- 1996.- Vol.94.-P.1818−1825.
- Kleiman N. Diabetes mellitus, glycoprotein Iib/Ша blockade and heparin. Evidence for a complex interection in a multicenter trial/ N. Kleiman et al.// Circulation.- 1998.- Vol. 98.- P.1912−1920.
- Koon-Hou M., David P. Clinical studies on coronary revascularization in patients with type 2 diabetes/ M. Koon-Hou, P. David// Eur. Heart J.- 2003.- Vol.24.-P.1087−1103.
- Kornowski R. Paradoxi decreases in atherosclerotic plaque in insulin-treated diabetic patients/ R. Kornowski et al.// Am. J. Cardiol.- 1998.- Vol.98.- P. 1298−1304.
- Kotronen A. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations/ A. Kotronen et al.// Diabetologia.- 2009.- Vol. 52, № 4.- P. 684- 691.
- Lau K. Midterm angiographic outcome of single-vessel intracoronary stent placement in diabetic versus nondiabetic patients: a matched comparative study/ K. Lau et al.// Am. Heart J.- 1998.- Vol.136.- P. 150−155.
- Lawrie G. Influence of diabetes mellitus on results of coronary artery bypass surgery/ G. Lawrie, G. Morris, D. Gleser// JAMA.- 1986.- Vol.256.- P.2967−2971.
- Levine O. For the CAVEAT-I Investigators. Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I)/ O. Levine et al.// Am. J. Cardiol.-1997.- Vol.79.- P.748−755.
- Libby P., Hansson G. Involvement of the immune system in human athe-rogenesis: current knowledgen and unanswered questions/ P. Libby, G. Hansson// Lab. Invest.- 1991.- Vol. 64.- P. 5−15.
- Lincoff A. Important Triad in Cardiovascular Medicine. Diabetes, Coronary Intervention, and Platelet Glycoprotein Ilb/IIIa Receptor Blockade/ A. Lincoff// Circulation.- 2003.- Vol. 107.- P. 1556.
- Natali A. Coronary atherosclerosis in type II diabetes: angiographic findings and clinical outcome/ A. Natali et al.// Diabetologia.- 2000.- Vol.43.- P.632−641.
- Loop F. Reoperation for coronary atherosclerosis. Changing practice in 2509 consecutive patients/ F. Loop et al.// Annals Surg.- 1990.- Vol. 212, — P.378−386.
- Lytle В., Loop F., Cosgrove D. Fifteen hundred coronary reoperations: results and determinants of early and lute survival/ B. Lytle, F. Loop, D. Cosgrove// J. Thoracic Cardiovasc. Surg.- 1987.- Vol.93.- P.847−859.
- Lytle В. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries/ B. Lytle// J. Thoracic Cardiovasc. Surg.- 1993.- Vol.105.- P.605−614.
- Magliano D. Lifetime risk and projected population prevalence of diabetes/ D. Magliano et al.// Diabetologia.- 2008.- Vol. 51, № 12.- P. 2179−2187.
- Мак К. Influence of diabetes mellitus on clinical outcome in the thrombolytic are of acute myocardial infarction/ К. Мак et al.// J. Am. Coll. Cardiol.-1997.- Vol.30.- P. 171−179.
- Marmot M. Biological and behavioural explanations of social inequalities in coronary heart disease: the Whitehall II study/ M. Marmot et al.// Diabetologia.-2008.-Vol.51, № 11.-P. 1980−1989.
- Marcheix B. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery/ B. Marcheix et al.// Ann. Thorac. Surg.- 2008.- Vol. 86, № 4.- P. 1181−1188.
- Mathew V. Comparative outcomes of percutaneous coronary interventions in diabetics vs non-diabetics with prior coronary artery bypass grafting/ V. Mathew et al.// Eur. Heart J.-2002.- Vol.23, № 18.- P. 1456−1464.
- Mathew V. Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: Changes in patient characteristics and outcome during two decades/V. Mathew et al.// Am. J. Med.- 2000.- Vol. 108.- P. 127−135.
- McLaughlin T. Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women/ T. McLaughlin et al.// Diabetologia.- 2008.- Vol.52, № 12.- P. 2303−2308.
- Morris J. Influence of diabetes and mammary artery grafting on survival after coronary bypass/ J. Morris et al.// Circulation.- 1991.- Vol.84(suppl.III).-P.III275−284.
- Ngaage D. Changing operative characteristics of patients undergoing operations for coronary artery disease: impact on early outcomes/ D. Ngaage et al.// Ann. Thorac. Surg.- 2008.- Vol. 86, № 5.- P. 1424−1430.
- Najafi M. Predictors of quality of life among patients undergoing coronary artery bypass surgery/ M. Najafi, M. Sheikhvatan, A. Montazeri, M. Sheikhfathollahi// Acta Cardiol.- 2008.- Vol. 63, № 6.- P. 713−721.
- Nathan D. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy/ D. Nathan et al.// Diabetes Care.- 2009.- Vol. 32, № 1.- P.193−205.
- O’Neill W. Multivessel balloon angiplasty should be abandoned in diabetic patients/ W. ONeill// J. Am. Coll. Cardiol.- 1998.- Vol. 31.- P. 20−22.
- Osende J. Blood thrombogenecity in type 2 diabetes mellitus patients is associated with glycemic control/ J. Osende// J. Am. Coll. Cardiol.- 2001.- Vol. 38.-P. 1307−1312.
- Otter W. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus/ W. Otter et al.// Diabet. Med.- 2004.- Vol.21.- P. 183 187.
- Papathanasiou A. Statin therapy is associated with reduced total and cardiovascular mortality after coronary artery bypass grafting surgery/ A. Papathanasiou et al.// Coron. Artery Dis.- 2008.- Vol. 19, № 8.- P. 619−625.
- Pazin-Filho A. HbA. c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study/ A. Pazin-Filho et al.]//Diabetologia.- 2008.- Vol. 51, № 12.- P. 2197−2204.
- Phillips P.J. Women, coronary artery disease and diabetes/ P.J. Phillips// Aust. Fam. Physician.- 2008.- Vol. 37, № 6.- P. 441−442.
- Piatti P.-M. Association of Insulin Resistance, Hyperleptinemia and Impaired Nitric Oxide Release With In-Stent Restenosis in Patients Undergoing Coronary Stenting/ P.-M. Piatti et al.// Circulation.- 2003.- Vol. 108.- P. 2074.
- Pick A. Third and fourth operations for myocardial ischemia: short-term results and long-term survival/ A. Pick et al.// Circulation.- 1997.- Vol. 96.- P.26−31.
- Pieper G., Langistroor P., Siebencich W. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals/ G. Pieper, P. Langistroor, W. Siebencich//Cardiovascular Res.- 1997.-Vol.34.-P. 145−156.
- Pyorala P. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Survival Study (4S)/P. Pyorala et al.// Diabetes Care.- 1997.- Vol. 20.- P. 614−620.
- Robins S. Fibrates and coronary heart disease reduction in diabetes/ S. Robins// Curr. Opin Endocrinol. Diabetes.- 2002.- Vol. 9.- P. 312−322.
- Rozenman Y. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus. A clue to the explanation of the results of the BARI study/ Y. Rozenman et al.// J. Am. Coll. Cardiol.- 1997.- Vol. 30.- P. 1420−1425.
- Santos S. Cirugia de revascularization coronaria en el paciente diabetic/ S. Santos, M. Ruiz// Rev. Esp. Cardiol.- 2002.- Vol.55, N12.- P.1311−1322.
- Savage M. Coronary intervention in the diabetic patient: improved outcome following stent implantation versus balloon angioplasty (abstract)/ M. Savage et al.// J. Am. Coll. Cardiol.- 2000.- Vol. 29, № 1.- P. 188A.
- Savarese V. Coronary artery disease screening in patients with diabetes/ V. Savarese, I. Ahmed, B.J. Goldstein// Endocrine.- 2008.- Vol. 54, № 11.- P. 11 841 192.
- Schofer J. Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study/ J. Schofer et al.// J. Am. Coll. Cardiol.- 2000.- Vol. 35.- P. 1554−1559.
- Smith L. Determinants of early versus late death in patients undergoing coronary artery bypass graft surgery/ L. Smith et al.// Circulation.- 1991.-Vol.84(suppl.III).- P. III245−253.
- Sousa J. Sustained suppression of neolntfmal proliferation by sirolimus-etutini stents one-year angiographic and intravascular ultrasound follow-up/ J. Sousa et al.// Circulation.- 2001.- Vol. 104.- P.2007−2011.
- Stratton I. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study/ I. Stratton et al.// BMJ.- 2000.- Vol.321.- P.405−412.
- Stehouwer C., Lambert J., Donker A., van Hinskbergh V. Endothelial dysfunction and pathogenesis of diabetic angiopathy/ C. Stehouwer, J. Lambert, A. Donker, V. van Hinskbergh// Cardiovascular Res.- 1997.- Vol.34.- P. 55−68.
- Stein B. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty/ B. Stein et al.// Circulation.-1995.- Vol.91.- P.979−989.
- Steiner G. Coronary artery disease in diabetes: results of the Diabetes Atherosclerosis intervention Study (DAIS)/ G. Steiner// Drug Benefit Trends.- 2001.-Vol. 13, Suppl. A.-P. S15-S21.
- Stephan W. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery/ W. Stephan et al.// J. Am. Coll. Cardiol.- 1996.-Vol. 28.-P. 1140−1146.
- Stout R. Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease/ R. Stout// Am. J. Med.- 1991.- Vol.90.- P. 62−65.
- Stumvol M. Type 2 diabetes: principles of pathogenesis and therapy/ M. Stumvol, B. Goldstein, T. Van Haeften// Lancet.- 2005.- Vol.365.- P. 1333−1346.
- Suselbeck T. Role of vessel sire as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus/ T. Suselbeck et al.// Am. J. Cardiol.- 2001.- Vol.88.- P. 243−247.
- Szendroedi J., Roden M. Mitochondrial fitness and insulin sensitivity in humans/ J. Szendroedi, M. Roden// Diabetologia.- 2008.- Vol.52, № 12.- P. 21 552 167.
- The BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status// J. Am. Coll. Cardiol.- 2000.- Vol. 35.- P. 1122−1129.
- The BARI Investigators. The Final 10-Year Follow-Up Results From the BARI Randomized Trial// J. Am. Coll Cardiol.- 2007.- Vol. 49.- P. 1600−1606.
- The FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial//Lancet.- 2005.- Vol. 366.- P. 1849−1861.
- Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of hige blood in adults (Adult Treatment Panel III)// JAMA.- 2001.- Vol. 285.- 2486−2497.
- Thourani V. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting/ V. Thourani et al.// Ann. Thorac. Surg.- 1999.-Vol.67.- P. 1045−1052.
- USPSTF: Screening for type 2 diabetes mellitus in adults: recommendations and rationale// Ann. Intern. Med.- 2003.- Vol. 138.- P.212−214.
- Van Belle E. Restenosis rates in diabetic patients. A comparison of coronary stenting and balloon angioplasty in native coronary vessels/ E. Van Belle et al.// Circulation.- 1997.- Vol.96.- P.1454−1460.
- Van Belle E. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients/ E. Van Belle et al.// J. Am. Coll. Cardiol.- 2002.- Vol. 40.- P. 410−417.
- Van Belle E. Patency of percutaneous transluminal coronary angioplasty sites at 6-nionlh angiographic follow-up/ E. Van Belle et al.// Circulation.- 2001.-Vol. 103.- P.1218−1224.
- Valensi P. All in one/ P. Valensi// Monde Moderne (France).- 2004.- P. 71−110, 184−209.
- Velianou J. Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation/ J. Velianou et al.// Am. J. Cardiol.-2000.- Vol.86.- P.1063−1068.
- Weintraub W. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease / W. Weintraub et al.// J. Am. Coll. Cardiol.- 1998.- Vol. 31.- P. 10−19.
- Wessely R. Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and desing/ R. Wessely et al.// Eur. Heart.J.- 2007.- Vol. 28, № 22.- P. 2720−2725.
- Woods S., Eppley C., Engel A. The influence of diabetes mellitus in patients undergoing coronary artery bypass graft surgery: a prospective cohort study/ S. Woods, C. Eppley, A. Engel// Am. Surg.- 2008.- Vol. 74, № 9.- P. 839−844.
- Yamoushi T. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells/ T. Yamoushi et al.// FEBS Lett.-1990, — Vol. 267.-P. 16−18.
- Zacharias A. Late results of conventional versus all-arterial revascularization based on internal thoracic and radial artery grafting/ A. Zacharias et al.// Ann Thorac. Surg.- 2009.- Vol. 87, № 1.- P. 19−26.